AUDUBON, Pa., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full ...

BofA analyst Craig Bijou upgraded Globus Medical (GMED) to Neutral from Underperform with a price target of $97, up from $80, after the company preannounced Q4 revenue that was 3% above the Street ...

KBC Group NV grew its position in shares of Globus Medical, Inc. (NYSE ... intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors ...

AUDUBON, Pa., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full-year ...

Globus Medical, Inc. (NYSE:GMED – Free Report ... plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors ...

Analyst Ryan Zimmerman from BTIG maintained a Buy rating on Globus Medical (GMED – Research Report) and keeping the price target at $91.00. Ryan Zimmerman’s rating is based on a combination of ...

Audubon, PA-based Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its ...

Vaporizable dried raw cannabis, or flower, could become legally available to Iowans who hold medical marijuana cards under a proposed House bill. The bill, House File 105, advanced Monday out of ...